It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication ...

Because of the difference in dosage, Ozempic is FDA-approved only to treat type 2 diabetes, while Wegovy is FDA-approved for weight loss. Likewise, Mounjaro and Zepbound are also identical ...

Medical professionals prescribing Ozempic for diabetes began noticing a common side effect: significant weight loss in many of their patients. This observation led to further studies, ultimately ...

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

Ozempic is approved for the management of type 2 diabetes, but it’s also used off-label to support weight loss. You can get Ozempic only by prescription via a reputable telehealth platform or in ...

BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...

Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...

Despite huge demand for the diabetes treatment-turned-weight-loss wonder drug, getting a prescription for Ozempic has been harder than scoring Eras Tour tickets. As word spread about its success ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...